-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Thursday's Intraday Session
Share
Listen to the news

Gainers

  • Pacira BioSciences (NASDAQ:PCRX) shares moved upwards by 44.0% to $36.3 during Thursday's regular session. The company's market cap stands at $1.0 billion.
  • Onconetix (NASDAQ:ONCO) stock rose 34.2% to $0.8. The company's market cap stands at $2.6 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 17.83% to $5.55. The company's market cap stands at $22.4 million.
  • GridAI Technologies (NASDAQ:GRDX) stock moved upwards by 17.71% to $4.85. The company's market cap stands at $29.3 million.
  • Haemonetics (NYSE:HAE) shares moved upwards by 17.58% to $119.6. The company's market cap stands at $4.6 billion.
  • Veradermics (NYSE:MANE) stock rose 16.13% to $128.85. The market value of their outstanding shares is at $4.6 billion.

Losers

  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares decreased by 87.7% to $0.35 during Thursday's regular session. The company's market cap stands at $1.5 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock fell 43.52% to $0.4. The market value of their outstanding shares is at $2.7 million.
  • Mobile-health Network (NASDAQ:MNDR) shares decreased by 36.12% to $0.97. The market value of their outstanding shares is at $1.8 million.
  • Stablecoin Development (AMEX:SDEV) stock declined by 30.25% to $1.94. The market value of their outstanding shares is at $75.3 million.
  • Caribou Biosciences (NASDAQ:CRBU) stock decreased by 25.22% to $0.46. The market value of their outstanding shares is at $66.1 million.
  • SCWorx Corp. - Common Stock (NASDAQ:WORX) shares fell 23.83% to $4.38. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending